Melanie Leveridge, SLAS2020 Co-Chair and Head of Screening, Profiling & Mechanistic Biology, GSK (UK), explores the hot drug discovery trends at SLAS2020, including artificial intelligence and cellular target engagement technologies for the progression of drug discovery projects. Leveridge also predicts the topics that will make an impact at SLAS2021, including omics technology and cell therapy.